LUMBY, BC, Oct. 1 /PRNewswire-FirstCall/ - avVaa World Health Care Products Inc. (Pink Sheets: AVVH), a global biotechnology company, manufacturer and distributor of nationally branded therapeutic, natural skin and health care products, announced that they will be launching their second test run of Neuroskin(R) Psoriasis Relief DRTV commercials the week of October 5, 2009.
avVaa World Health Care Products will launch a two week DRTV test run for Neuroskin(R) Psoriasis Relief beginning the week of October 5, 2009. The first week will feature a 2 minute soft offer commercial, and the second week will feature a 2 minute hard offer commercial. While the hard offer displays the product price of $34.95, the soft offer displays no price. Each offer has benefits and drawbacks, and the test will help determine which one produces the best sales.
"With the hard offer, the price is given up front, and many customers like that," stated Lorie Campbell-Farley, President and Chief Operating Officer. "But those customers may only purchase one unit, because their cost expectation was set when watching the commercial. A soft offer will generate more inquiries, and customers may be more easily upsold, however some callers will end the conversation when they find out the price. The goal is to find which offer works best with Neuroskin(R)."
The DRTV commercials are in infomercial format. Over 50 commercials will run each week, most being 2 minutes long. "Synergixx is working with the networks to get us additional free spots for 60 and 30 second commercials," commented Mrs. Campbell-Farley. To facilitate this, Creative Bube Tube has added a 30 second DRTV commercial to Neuroskin's(R) DRTV repertoire.
"With our first media test, we were able to work out the kinks in our processes and in vendor communications. We took what we learned and made the changes that were needed, such as changing media buyers, adding echeck, and streamlining our credit card processing. We're ready to hit the road running with this test, and we anticipate a much better return on our investment," concluded Lorie Campbell-Farley.
About avVaa World Health Care Products
avVaa World Health Care Products is a global biotechnology company that specializes in effective, all natural, therapeutic skin care products that improve quality of life and well being for consumers. avVaa's patented European skin care formulas are scientifically registered, FDA-Compliant, and were developed to relieve and treat the symptoms of common skin ailments, including eczema, psoriasis and acne. avVaa is poised to manufacture and market its OTC Neuroskin(R)) line of skin care products through mass, food and drug channels in the United States and globally. The Company's secondary line of equine and pet care related products are already being distributed throughout all of Canada. For more information, visit: www.avvaa.com.
Safe Harbor: Statements contained in this press release that are not based upon current or historical fact are forward looking in nature. Such forward-looking statements are subject to risks and uncertainties, which could cause actual results to differ materially from estimated results. Management cautions that all statements as to future results of operations are necessarily subject to risks, uncertainties, and events that may be beyond the control of avVaa World Health Care Products, Inc. and no assurance can be given that such results will be achieved.
Potential risks and uncertainties include but are not limited to the ability to procure, properly price, retain, and successfully complete projects, the availability of technical personnel, changes in technology, and competition.
SOURCE avVaa World Health Care Products
|SOURCE avVaa World Health Care Products|
Copyright©2009 PR Newswire.
All rights reserved